• レポートコード:GIR-107A14921 • 出版社/出版日:GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、105ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医薬品 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、アルモダフィニルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルモダフィニルの種類別市場規模(50mg錠、150mg錠、200mg錠、250mg錠)、用途別市場規模(閉塞性睡眠時無呼吸(OSA)・ナルコレプシー、交代勤務障害(SWD)、重度肝機能障害患者、高齢患者)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アルモダフィニルの市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Teva、Mylan、Apotex、Lupin、Sandoz、Natco Pharma、Aurobindo ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:50mg錠、150mg錠、200mg錠、250mg錠 ・用途別分析2016年-2026年:閉塞性睡眠時無呼吸(OSA)・ナルコレプシー、交代勤務障害(SWD)、重度肝機能障害患者、高齢患者 ・アルモダフィニルの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・アルモダフィニルのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・アルモダフィニルのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・アルモダフィニルの南米市場規模2016年-2026年:ブラジル、アルゼンチン ・アルモダフィニルの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Armodafinil market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Armodafinil size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Armodafinil market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Armodafinil market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
50 mg Tablets
150 mg Tablets
200 mg Tablets
250 mg Tablets
Market segment by Application, can be divided into
Obstructive Sleep Apnea (OSA) and Narcolepsy
Shift Work Disorder (SWD)
Patients with Severe Hepatic Impairment
Geriatric Patients
Market segment by players, this report covers
Teva
Mylan
Apotex
Lupin
Sandoz
Natco Pharma
Aurobindo
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Armodafinil
1.2 Classification of Armodafinil by Type
1.2.1 Overview: Global Armodafinil Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Armodafinil Revenue Market Share by Type in 2020
1.2.3 50 mg Tablets
1.2.4 150 mg Tablets
1.2.5 200 mg Tablets
1.2.6 250 mg Tablets
1.3 Global Armodafinil Market by Application
1.3.1 Overview: Global Armodafinil Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
1.3.3 Shift Work Disorder (SWD)
1.3.4 Patients with Severe Hepatic Impairment
1.3.5 Geriatric Patients
1.4 Global Armodafinil Market Size & Forecast
1.5 Global Armodafinil Market Size and Forecast by Region
1.5.1 Global Armodafinil Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Armodafinil Market Size by Region, (2016-2021)
1.5.3 North America Armodafinil Market Size and Prospect (2016-2026)
1.5.4 Europe Armodafinil Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Armodafinil Market Size and Prospect (2016-2026)
1.5.6 South America Armodafinil Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Armodafinil Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Armodafinil Market Drivers
1.6.2 Armodafinil Market Restraints
1.6.3 Armodafinil Trends Analysis
2 Company Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Armodafinil Product and Solutions
2.1.4 Teva Armodafinil Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Teva Recent Developments and Future Plans
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Armodafinil Product and Solutions
2.2.4 Mylan Armodafinil Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Mylan Recent Developments and Future Plans
2.3 Apotex
2.3.1 Apotex Details
2.3.2 Apotex Major Business
2.3.3 Apotex Armodafinil Product and Solutions
2.3.4 Apotex Armodafinil Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Apotex Recent Developments and Future Plans
2.4 Lupin
2.4.1 Lupin Details
2.4.2 Lupin Major Business
2.4.3 Lupin Armodafinil Product and Solutions
2.4.4 Lupin Armodafinil Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Lupin Recent Developments and Future Plans
2.5 Sandoz
2.5.1 Sandoz Details
2.5.2 Sandoz Major Business
2.5.3 Sandoz Armodafinil Product and Solutions
2.5.4 Sandoz Armodafinil Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sandoz Recent Developments and Future Plans
2.6 Natco Pharma
2.6.1 Natco Pharma Details
2.6.2 Natco Pharma Major Business
2.6.3 Natco Pharma Armodafinil Product and Solutions
2.6.4 Natco Pharma Armodafinil Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Natco Pharma Recent Developments and Future Plans
2.7 Aurobindo
2.7.1 Aurobindo Details
2.7.2 Aurobindo Major Business
2.7.3 Aurobindo Armodafinil Product and Solutions
2.7.4 Aurobindo Armodafinil Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Aurobindo Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Armodafinil Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Armodafinil Players Market Share
3.2.2 Top 10 Armodafinil Players Market Share
3.2.3 Market Competition Trend
3.3 Armodafinil Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Armodafinil Revenue and Market Share by Type (2016-2021)
4.2 Global Armodafinil Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Armodafinil Revenue Market Share by Application (2016-2021)
5.2 Armodafinil Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Armodafinil Revenue by Type (2016-2026)
6.2 North America Armodafinil Revenue by Application (2016-2026)
6.3 North America Armodafinil Market Size by Country
6.3.1 North America Armodafinil Revenue by Country (2016-2026)
6.3.2 United States Armodafinil Market Size and Forecast (2016-2026)
6.3.3 Canada Armodafinil Market Size and Forecast (2016-2026)
6.3.4 Mexico Armodafinil Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Armodafinil Revenue by Type (2016-2026)
7.2 Europe Armodafinil Revenue by Application (2016-2026)
7.3 Europe Armodafinil Market Size by Country
7.3.1 Europe Armodafinil Revenue by Country (2016-2026)
7.3.2 Germany Armodafinil Market Size and Forecast (2016-2026)
7.3.3 France Armodafinil Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Armodafinil Market Size and Forecast (2016-2026)
7.3.5 Russia Armodafinil Market Size and Forecast (2016-2026)
7.3.6 Italy Armodafinil Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Armodafinil Revenue by Type (2016-2026)
8.2 Asia-Pacific Armodafinil Revenue by Application (2016-2026)
8.3 Asia-Pacific Armodafinil Market Size by Region
8.3.1 Asia-Pacific Armodafinil Revenue by Region (2016-2026)
8.3.2 China Armodafinil Market Size and Forecast (2016-2026)
8.3.3 Japan Armodafinil Market Size and Forecast (2016-2026)
8.3.4 South Korea Armodafinil Market Size and Forecast (2016-2026)
8.3.5 India Armodafinil Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Armodafinil Market Size and Forecast (2016-2026)
8.3.7 Australia Armodafinil Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Armodafinil Revenue by Type (2016-2026)
9.2 South America Armodafinil Revenue by Application (2016-2026)
9.3 South America Armodafinil Market Size by Country
9.3.1 South America Armodafinil Revenue by Country (2016-2026)
9.3.2 Brazil Armodafinil Market Size and Forecast (2016-2026)
9.3.3 Argentina Armodafinil Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Armodafinil Revenue by Type (2016-2026)
10.2 Middle East & Africa Armodafinil Revenue by Application (2016-2026)
10.3 Middle East & Africa Armodafinil Market Size by Country
10.3.1 Middle East & Africa Armodafinil Revenue by Country (2016-2026)
10.3.2 Turkey Armodafinil Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Armodafinil Market Size and Forecast (2016-2026)
10.3.4 UAE Armodafinil Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Armodafinil Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Armodafinil Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Armodafinil Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Armodafinil Revenue (USD Million) by Region (2016-2021)
Table 5. Global Armodafinil Revenue Market Share by Region (2021-2026)
Table 6. Teva Corporate Information, Head Office, and Major Competitors
Table 7. Teva Major Business
Table 8. Teva Armodafinil Product and Solutions
Table 9. Teva Armodafinil Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Mylan Corporate Information, Head Office, and Major Competitors
Table 11. Mylan Major Business
Table 12. Mylan Armodafinil Product and Solutions
Table 13. Mylan Armodafinil Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Apotex Corporate Information, Head Office, and Major Competitors
Table 15. Apotex Major Business
Table 16. Apotex Armodafinil Product and Solutions
Table 17. Apotex Armodafinil Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Lupin Corporate Information, Head Office, and Major Competitors
Table 19. Lupin Major Business
Table 20. Lupin Armodafinil Product and Solutions
Table 21. Lupin Armodafinil Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sandoz Corporate Information, Head Office, and Major Competitors
Table 23. Sandoz Major Business
Table 24. Sandoz Armodafinil Product and Solutions
Table 25. Sandoz Armodafinil Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Natco Pharma Corporate Information, Head Office, and Major Competitors
Table 27. Natco Pharma Major Business
Table 28. Natco Pharma Armodafinil Product and Solutions
Table 29. Natco Pharma Armodafinil Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Aurobindo Corporate Information, Head Office, and Major Competitors
Table 31. Aurobindo Major Business
Table 32. Aurobindo Armodafinil Product and Solutions
Table 33. Aurobindo Armodafinil Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Armodafinil Revenue (USD Million) by Players (2019-2021)
Table 35. Global Armodafinil Revenue Share by Players (2019-2021)
Table 36. Breakdown of Armodafinil by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Armodafinil Players Head Office, Products and Services Provided
Table 38. Armodafinil Mergers & Acquisitions in the Past Five Years
Table 39. Armodafinil New Entrants and Expansion Plans
Table 40. Global Armodafinil Revenue (USD Million) by Type (2016-2021)
Table 41. Global Armodafinil Revenue Share by Type (2016-2021)
Table 42. Global Armodafinil Revenue Forecast by Type (2021-2026)
Table 43. Global Armodafinil Revenue by Application (2016-2021)
Table 44. Global Armodafinil Revenue Forecast by Application (2021-2026)
Table 45. North America Armodafinil Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Armodafinil Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Armodafinil Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Armodafinil Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Armodafinil Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Armodafinil Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Armodafinil Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Armodafinil Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Armodafinil Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Armodafinil Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Armodafinil Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Armodafinil Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Armodafinil Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Armodafinil Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Armodafinil Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Armodafinil Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Armodafinil Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Armodafinil Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Armodafinil Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Armodafinil Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Armodafinil Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Armodafinil Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Armodafinil Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Armodafinil Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Armodafinil Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Armodafinil Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Armodafinil Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Armodafinil Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Armodafinil Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Armodafinil Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Armodafinil Picture
Figure 2. Global Armodafinil Revenue Market Share by Type in 2020
Figure 3. 50 mg Tablets
Figure 4. 150 mg Tablets
Figure 5. 200 mg Tablets
Figure 6. 250 mg Tablets
Figure 7. Armodafinil Revenue Market Share by Application in 2020
Figure 8. Obstructive Sleep Apnea (OSA) and Narcolepsy Picture
Figure 9. Shift Work Disorder (SWD) Picture
Figure 10. Patients with Severe Hepatic Impairment Picture
Figure 11. Geriatric Patients Picture
Figure 12. Global Armodafinil Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Armodafinil Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Armodafinil Revenue Market Share by Region (2016-2026)
Figure 15. Global Armodafinil Revenue Market Share by Region in 2020
Figure 16. North America Armodafinil Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Armodafinil Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Armodafinil Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Armodafinil Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Armodafinil Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Armodafinil Market Drivers
Figure 22. Armodafinil Market Restraints
Figure 23. Armodafinil Market Trends
Figure 24. Teva Recent Developments and Future Plans
Figure 25. Mylan Recent Developments and Future Plans
Figure 26. Apotex Recent Developments and Future Plans
Figure 27. Lupin Recent Developments and Future Plans
Figure 28. Sandoz Recent Developments and Future Plans
Figure 29. Natco Pharma Recent Developments and Future Plans
Figure 30. Aurobindo Recent Developments and Future Plans
Figure 31. Global Armodafinil Revenue Share by Players in 2020
Figure 32. Armodafinil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Armodafinil Revenue Market Share in 2020
Figure 34. Global Top 10 Players Armodafinil Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Armodafinil Revenue Share by Type in 2020
Figure 37. Global Armodafinil Market Share Forecast by Type (2021-2026)
Figure 38. Global Armodafinil Revenue Share by Application in 2020
Figure 39. Global Armodafinil Market Share Forecast by Application (2021-2026)
Figure 40. North America Armodafinil Sales Market Share by Type (2016-2026)
Figure 41. North America Armodafinil Sales Market Share by Application (2016-2026)
Figure 42. North America Armodafinil Revenue Market Share by Country (2016-2026)
Figure 43. United States Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Armodafinil Sales Market Share by Type (2016-2026)
Figure 47. Europe Armodafinil Sales Market Share by Application (2016-2026)
Figure 48. Europe Armodafinil Revenue Market Share by Country (2016-2026)
Figure 49. Germany Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Armodafinil Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Armodafinil Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Armodafinil Revenue Market Share by Region (2016-2026)
Figure 57. China Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Armodafinil Sales Market Share by Type (2016-2026)
Figure 64. South America Armodafinil Sales Market Share by Application (2016-2026)
Figure 65. South America Armodafinil Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Armodafinil Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Armodafinil Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Armodafinil Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Armodafinil Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source